Call for Abstract

5th International Conference on Bacteriology, will be organized around the theme “Advances and Challenges in Bacteriology during Covid-19 Pandemic”

Bacteriology 2020 is comprised of 17 tracks and 65 sessions designed to offer comprehensive sessions that address current issues in Bacteriology 2020.

Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.

Register now for the conference by choosing an appropriate package suitable to you.

  • Track 1-1Bacterial genome evolution
  • Track 1-2Genome comparisons and phylogeny
  • Track 1-3Genomic reduction

Bacterial vaginosis is an abnormal vaginal condition that is characterized by vaginal discharge and results from an overgrowth of atypical bacteria in the vagina. It is not a true bacterial infection but rather an imbalance of the bacteria that are normally present in the vagina. Usually treatment is with an antibiotic, such as clindamycin or metronidazole. BV is the most common vaginal infection in women of reproductive age. In the United States about 30% of women between the ages of 14 and 49 are affected. BV is linked to an imbalance of “good” and “harmful” bacteria that are normally found in a woman’s vagina. Bacterial vaginosis results from overgrowth of one of several bacteria naturally found in your vagina. Usually, "good" bacteria (lactobacilli) outnumber "bad" bacteria (anaerobes). But if there are too many anaerobic bacteria, they upset the natural balance of microorganisms in your vagina and cause bacterial vaginosis. BV is a polymicrobial clinical syndrome resulting from replacement of the normal hydrogen peroxide producing Lactobacillus sp. in the vagina with high concentrations of anaerobic bacteria (e.g., Prevotella sp. and Mobiluncus sp.), G. vaginalis, Ureaplasma, Mycoplasma, and numerous fastidious or uncultivated anaerobes. Some women experience transient vaginal microbial changes, whereas others experience them for longer intervals of time.

  • Track 2-1Abnormal vaginal odor
  • Track 2-2Abnormal consistency of vaginal fluid
  • Track 2-3Vaginal pain
  • Track 2-4Vaginal burning
  • Track 3-1Mutualism
  • Track 3-2Commensalism
  • Track 3-3Amensalism
  • Track 3-4Antimicrobials
  • Track 4-1Animal health
  • Track 4-2Zoonoses
  • Track 4-3Food safety
  • Track 4-4Preventive measures
  • Track 5-1Evolution of bacteriology pathogens
  • Track 5-2Classification of plant- pathogenic bacteria
  • Track 5-3Epidemiology and control of bacterial plant diseases
  • Track 5-4Future prospects in plant bacteriology
  • Track 6-1Microbial
  • Track 6-2Viral pathogenesis
  • Track 6-3Immunological host response to infections
  • Track 6-4Tumour immunity
  • Track 6-5Immunodeficiency
  • Track 7-1 Applications and innovations
  • Track 7-2Scientic methods oriented towards natural sciences
  • Track 7-3Environment and health risk assessment and management
  • Track 7-4Research methods in environmental science
  • Track 8-1Applications of viral vectors
  • Track 8-2Industrial processes end products
  • Track 8-3Bioprocess engineering and systems biology
  • Track 8-4Microfactories-microbial production
  • Track 9-1Biochemical testing
  • Track 9-2Hybridization-based detection
  • Track 9-3Molecular diagnostic methods for bacterial detection
  • Track 9-4Amplification methods
  • Track 10-1Naturopathy for bacterial infections
  • Track 10-2MARS
  • Track 10-3Pharmacology of antibiotics
  • Track 11-1Bacterial nutrition
  • Track 11-2Bacterial growth
  • Track 11-3Bacterial metabolism
  • Track 11-4Bacterial replication
  • Track 12-1Bacterial pneumonia
  • Track 12-2Cholera.
  • Track 12-3Leprosy
  • Track 12-4Tuberculosis
  • Track 12-5Plague
  • Track 13-1Bacterial reactions
  • Track 13-2Molecular Biology
  • Track 13-3Toxicity of antibiotics
  • Track 14-1Clinical trials of antibiotics
  • Track 14-2Bacterial clinical studies
  • Track 14-3Clinical Microbiology and Infection
  • Track 15-1Intracellular growth
  • Track 15-2Pathogenic mechanisms
  • Track 15-3Bacterial Infectivity
  • Track 15-4Bacterial resistance
  • Track 16-1Emerging infectious diseases
  • Track 16-2Urinary tract infection (UTI)
  • Track 16-3Bacteriology of dental infections
  • Track 17-1Antibiotics in oncology
  • Track 17-2Antibiotics in our food system
  • Track 17-3Antibiotic regulatory affairs
  • Track 17-4Antibiotic resistance